Latest news – page 2 of 9
205 postsThe whole feed in date order, from all five sections.
The August top list on Eqvor is in
Blykalla is both the most traded share and the one that rose the most of them — up 28.0% over the month.
Blykalla raised around USD 50 million in 2025 — cash rose from 73 to 445 MSEK
Blykalla AB's annual report for 2025 reports a capital raise of around USD 50 million with Nasdaq-listed Oklo as lead investor. Test rigs were commissioned at ARTS outside Oskarshamn and the average number of employees went from 20 to 38.
Virtual group presentation with Estrid — 9 September at 14:00
Estrid's CEO and co-founder Ben Eliass presents the company to Eqvor's customers. In 2025 Estrid made a deliberate shift towards profitability — now he explains where the company stands today, where it is heading, and answers questions directly from participants.
Mynt had revenue of SEK 120.3 million in 2025 — expansion and partnerships behind the growth
Mynt AB reports net sales of SEK 120.3 million for the 2025 financial year, compared with 72.3 million the year before. The directors' report cites expansion into new geographical markets and new partnerships as the reason.
Sigrid Therapeutics 2025: revenue up 648 per cent and loss down 49 per cent
Sigrid Therapeutics has submitted its annual report for 2025. Net sales rose to 12.8 MSEK, the loss narrowed to 22.1 MSEK and the equity ratio strengthened to 78 per cent. During the year the company entered into an exclusive global licensing and research collaboration.
Hedvig is now on Eqvor
The insurance company that sells and manages insurance digitally in its own app. More than 200,000 people have chosen Hedvig. From today, the share is open for trading on the platform.
Northmill increased profit before tax by 54 per cent in the second quarter
Northmill Group AB (publ) reports 86 MSEK in profit before tax for the second quarter of 2026, compared with 56 MSEK in the same quarter the previous year. The total portfolio grew 64 per cent to 7,765 MSEK, driven by business lending.
GreenGold acquired a net 1,098 hectares in the quarter — forest assets valued at EUR 728 million
The forest investment company GreenGold Group acquired a net 1,098 hectares of forest properties in the second quarter of 2026 and owned 81.4 thousand hectares of land at the end of the period.
Nordiska Q2 2026: operating income up 27.8 per cent and the Bliq acquisition completed
Nordiska reports operating income of 217.4 MSEK and a profit of 67.0 MSEK for the second quarter. Lending grew to 11.2 MDSEK and the capital ratios were strengthened — at the same time, two one-off effects pulled the result in opposite directions.
Svea Solar narrowed its operating loss in 2025 — revenue down 21 per cent
The annual report for 2025 shows net sales of 1,083 MSEK and an operating profit of -507 MSEK, compared with -723 MSEK the year before. After the balance sheet date, the company has acquired assets from Sesol's bankruptcy estate.
Measurable. Noticeable.
This week's news from the unlisted shares on Eqvor: Sigicom joins the platform, Hasko Invest delivers a very strong second quarter with 58 per cent growth, Storsala carries out its largest directed share issue to date and Kaunis Iron opens talks with…
Sigicom listed on Eqvor
The measurement technology company that monitors vibrations and noise at construction and infrastructure projects. Founded in 1981 in Tullinge, today 266 million in revenue and subsidiaries in six countries besides Sweden. From today the share is open for trading on the platform.
A3P Biomedical: study shows 90 per cent sensitivity for Stockholm3 — net sales down 61 per cent
Net sales amounted to 2.8 MSEK in the second quarter, a decrease of 61 per cent that the company mainly attributes to sales being conducted in the form of pilot projects.
Hasko delivers a very strong second quarter of 2026
Hasko Invest AB (publ) has published its interim report for January–June 2026. The company is growing strongly both organically and through acquisitions – and unlike many acquisition-driven groups, the growth is coming with rising, not squeezed, margins.
The tracks are laid.
This week's news from the unlisted shares on Eqvor: Doktor.se reports a strong half-year with SEK 1.5 billion in financing, Sigrid Therapeutics grows sales 53 per cent and gets the SHINE study published, Quartr raises the figure for its funding round to 18…
Virtune: 367 MSEK in net inflows — weak crypto market turned the result negative
Assets under management amounted to SEK 2.24 billion at the half-year mark. Net sales decreased by 29 per cent and EBITDA amounted to -10,618 KSEK, while the company had positive net inflows in every month of the period.
Sigrid Therapeutics H1 2026 – sales up 53 per cent and the SHINE study published
Sigrid Therapeutics has published its shareholder report for the first half of 2026. Sales rose 53 per cent compared with the same period last year, the clinical SHINE study was published in the Lancet family's eClinicalMedicine and CE marking remains on…
Doktor.se delivers a strong first half of 2026 – summary of the CEO's letter to shareholders
Doktor.se has published its letter to shareholders for the first half of 2026, and there is plenty to be pleased about. The company is delivering growth and improved profitability – ahead of budget on both counts – and has also secured new financing of SEK 1.5 billion from…
Eqvor appoints Viktor Sarström as CTO
Eqvor announces that Viktor Sarström has taken up the position of Chief Technology Officer. Sarström, who started on Monday 3 August, joins most recently from Quartr and brings 22 years of experience as a developer and architect.
Slower breakdown. Broader reach.
This week's news from the unlisted shares on Eqvor: Sigrid Therapeutics reaches US healthcare providers through Fullscript, Novedo is back to organic growth, Dirac grows revenue but swings to a loss and Nordiska takes its AT1 bonds to Nasdaq…
Dirac: Annual report 2026
The audio software company Dirac increased net sales to 212.9 MSEK in 2025, driven by the Home Audio segment, which grew 41 per cent. At the same time, operating profit turned into a loss of 0.7 MSEK, weighed down by higher costs — mainly staff — and an impairment…
Novedo Q2 2026: back to organic growth
Novedo’s net sales increased 18.0 per cent in the second quarter and the group returned to organic growth after a long slump. The order backlog — orders received but not yet carried out — was considerably larger than a year earlier.
Sigrid Therapeutics launches on Fullscript
The company’s first large-scale distribution platform to healthcare providers in the US. Two products. North America’s leading healthcare provider platform.
New episode of Vägen till Exit: Where do you park your money when the stock market shakes?
When the stock market shakes, most people know what they don't want to do. Fewer know what they should do. In this week's episode we meet Mikael Yman — a fixed-income manager with an answer built on real portfolios, not theory.
